Elanco, the animal health division of Eli Lilly and Company, today announced the company will purchase the Titanium and Master Guard brands from AgriLabs. These well-known cattle vaccine brands will complement Elanco’s growing vaccine portfolio, including the recently approved ViralignTM 6, the only modified-live combination vaccine to protect against bovine viral diarrhea (BVD) virus 1b, which is now the most predominant BVD virus strain in the United States.
Elanco will continue to deliver these highly respected brands in the same manner producers have come to expect and will work closely with AgriLabs to ensure a seamless transition. Elanco will support all 2013 programs and pricing, and customers should continue to place orders through existing channels.
"At Elanco, we are committed to providing innovative solutions to enhance food production and companion animal care. We are pleased our growing vaccine portfolio and pipeline will offer Elanco customers a broader array of options to better meet their specific needs for disease prevention," said Jeff Simmons, president, Elanco. "This is another example of our effort to provide Elanco customers with greater value."
In the next few decades, global population is expected to exceed 9 billion, and 3 billion will move into the middle class, the fastest middle class growth in our history. With the growing affluence, will come a 60 percent increase in demand for meat, milk and eggs, according to the U.N. Food and Agriculture Organization.
"With beef stocks at all-time lows and demand outpacing dairy supply globally, we must continue to provide innovative solutions that will help producers increase the affordability and availability of animal protein," said Rob Aukerman, president U.S. operations at Elanco. "We have diversified our portfolio and sources of innovation to deliver more options and solutions to our customers."
AgriLabs (www.agrilabs.com) is a leading animal health, sales and marketing organization with distribution throughout the United States. Through technology transfer and cooperative development agreements, AgriLabs has introduced state-of-the-art products for beef, dairy and companion animal industries. The wholly owned ProLabs® (www.prolabpets.com) division focuses on new product development of companion animal products into the over-the-counter channel. The VaxLiant™ (www.vaxliant.com) company is a joint venture with Benchmark Biolabs designed to modernize how vaccines deliver antigens to prevent disease with its ENABL™ and Biomize™ adjuvants.
Elanco is a global, innovation-driven company that develops and markets products to improve animal health and protein production in more than 75 countries. Elanco employs more than 2,500 people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company, a leading global pharmaceutical corporation. Additional information about Elanco is available at www.elanco.com.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.